KONSTANTINOS KATOPODIS

Mr. KONSTANTINOS KATOPODIS

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Panagiotis BarmpalexisPanagiotis Barmpalexis
Panagiotis Barmpalexis
AKAnna Karagianni
Anna Karagianni
KKKONSTANTINOS KATOPODIS
KONSTANTINOS KATOPODIS
Elisavet VardakaElisavet Vardaka
Elisavet Vardaka
Kyriakos KachrimanisKyriakos Kachrimanis
Kyriakos Kachrimanis

1 April 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Afroditi KapouraniAfroditi Kapourani
Afroditi Kapourani
Elisavet VardakaElisavet Vardaka
Elisavet Vardaka
KKKONSTANTINOS KATOPODIS
KONSTANTINOS KATOPODIS
Kyriakos KachrimanisKyriakos Kachrimanis
Kyriakos Kachrimanis
Panagiotis BarmpalexisPanagiotis Barmpalexis
Panagiotis Barmpalexis

1 December 2019 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Afroditi KapouraniAfroditi Kapourani
Afroditi Kapourani
Elisavet VardakaElisavet Vardaka
Elisavet Vardaka
KKKONSTANTINOS KATOPODIS
KONSTANTINOS KATOPODIS
Kyriakos KachrimanisKyriakos Kachrimanis
Kyriakos Kachrimanis
Panagiotis BarmpalexisPanagiotis Barmpalexis
Panagiotis Barmpalexis

1 March 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
KKKONSTANTINOS KATOPODIS
KONSTANTINOS KATOPODIS
Afroditi KapouraniAfroditi Kapourani
Afroditi Kapourani
Elisavet VardakaElisavet Vardaka
Elisavet Vardaka
Anna KaragianniAnna Karagianni
Anna Karagianni
CCChristina Chorianopoulou
Christina Chorianopoulou
Panagiotis BarmpalexisPanagiotis Barmpalexis
Panagiotis Barmpalexis

13 March 2024 in Polymers
Verified
Journal Article
Open access
PDF file
Afroditi KapouraniAfroditi Kapourani
Afroditi Kapourani
KKKONSTANTINOS KATOPODIS
KONSTANTINOS KATOPODIS
VVVasiliki Valkanioti
Vasiliki Valkanioti
MCMelina Chatzitheodoridou
Melina Chatzitheodoridou
CCChris Cholevas
Chris Cholevas
Panagiotis BarmpalexisPanagiotis Barmpalexis
Panagiotis Barmpalexis
The application of mesoporous carriers in formulations of amorphous solid dispersions (ASDs) has been suggested to enhance the stability of amorphous drugs. However, mesoporous carriers do not demonstrate satisfactory inhibitory effects on the precipitation of active pharmaceutical ingredients (APIs), and the inclusion of an appropriate polymer within ASDs becomes imperative to maintaining drug supersaturation. The aim of this study was to evaluate ternary olanzapine (OLN) ASDs with Syloid 244FP and to find an appropriate polymeric carrier. The polymer’s selection criteria were based on the physical stability of the ASDs and the release rate of the drug from the systems. The polymers investigated were hydroxypropylmethyl cellulose (HPMC) and copovidone (coPVP). The formation of ASDs was achievable in all investigated cases, as demonstrated by the complete lack of crystallinity confirmed through both powder X-ray diffraction (pXRD) analysis and differential scanning calorimetry (DSC) for all developed formulations. The solvent shift method was employed to evaluate the ability of the studied carriers to inhibit the precipitation of supersaturated OLN. coPVP emerged as a more suitable precipitation inhibitor compared with HPMC and Syloid 244 FP. Subsequently, in vitro dissolution studies under non-sink conditions revealed a higher degree of supersaturation in ternary systems where coPVP was used as a polymeric carrier, as these systems exhibited, under the examined conditions, up to a 2-fold increase in the released OLN compared with the pure crystalline drug. Moreover, stability studies conducted utilizing pXRD demonstrated that ternary formulations incorporating coPVP and Syloid 244 FP maintained stability for an extended period of 8 months. In contrast, binary systems exhibited a comparatively shorter stability duration, indicating the synergistic effect of coPVP and Syloid 244 FP on the physical stability of the amorphous API. Attenuated total reflectance–Fourier transform infrared (ATR-FTIR) studies showed that the development of stronger molecular interactions can be provided as an explanation for this synergistic effect, as the formation of robust H-bonds may be considered responsible for inhibiting the precipitation of the supersaturated API. Therefore, the incorporation of coPVP into OLN ASDs with Syloid 244 FP is considered a highly promising technique for increasing the degree of OLN supersaturation in in vitro dissolution studies and improving the stability of systems.